Clavulanate Potassium Market
- 2026 年市場規模
- USD 1,742.6 Mn
- 2033 年預估規模
- USD 2,574.8 Mn
- 年複合成長率 CAGR
- 5.7%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Clavulanate Potassium Market, By Formulation Type (Oral Formulations and Injectable Formulations), By Application (Respiratory Tract Infections, Urinary Tract Infections, Skin and Soft Tissue Infections, and Other Bacterial Infections), By End User (Hospitals, Clinics, Homecare Settings, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The global clavulanate potassium market is estimated to be valued at USD 1,742.6 Mn in 2026 and is expected to reach USD 2,574.8 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 5.7% from 2026 to 2033. Clavulanate potassium is a prominent product within the global pharmaceutical industry as it is a crucial component used in combination with beta-lactam antibiotics, such as amoxicillin. This medication works by inhibiting beta-lactamase enzyme released from bacteria and preventing its effects on amoxicillin, thus expanding the antibacterial coverage. It is prescribed as part of various combined medications to treat infections of the respiratory tract, urinary tract, skin and soft tissue, ear, and various dental infections.
The market consists of pharmaceutical manufacturers, generic drug makers and biotech companies which is involved in the development, manufacturing, and sale of clavulanate potassium-based drugs. The increase in prevalence of bacterial infection, rise in healthcare expenditure, growing concern over the development of antimicrobial resistance and the increase in availability of healthcare services in emerging economies are driving the growth of this market. In addition, growing pharmaceutical production capacity, increased availability of generic medications, and rising demand by hospital, clinic, retail pharmacy and the internet distribution channel in worldwide is reinforcing the market trends.
Market Dynamics
The global clavulanate potassium market is primarily driven by the increasing number of bacterial infections, the rising threat of antibiotic resistance globally, and the growing importance of beta-lactamase inhibitors in rendering commonly used antibiotics more effective against various drug-resistant bacterial strains. Increasing expenditure in healthcare sector, access to healthcare services in developing nations, and better understanding about use of antibiotics, rising number of old age population across the world is also driving the market.
However, market growth is impeded by stringent regulatory compliances and time-consuming approval procedures. Patent expiry for branded drugs and the growing menace of antibiotic-induced adverse effects and resistance development continue to impede market growth. Nevertheless, ample opportunities are being generated through the launch of new formulations and the advent of new manufacturing techniques. The growth trend is boosted with growing demand for combination therapies and rising application of the products in veterinary medicine. Moreover, the development of better healthcare infrastructure in underdeveloped economies along with business alliances between pharmaceutical firms further opens up new vistas for growth.
Key Features of the Study
• This report provides in-depth analysis of the global clavulanate potassium market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global clavulanate potassium market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GSK plc, Sandoz Group AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Lupin Limited, CSPC Pharmaceutical Group Limited, North China Pharmaceutical Group Corporation, United Laboratories International Holdings Limited, and ACS Dobfar S.p.A.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global clavulanate potassium market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global clavulanate potassium market
Market Segmentation
• Formulation Type Insights (Revenue, USD Mn, 2021 - 2033)
o Oral Formulations
o Injectable Formulations
• Application Insights (Revenue, USD Mn, 2021 - 2033)
o Respiratory Tract Infections
o Urinary Tract Infections
o Skin and Soft Tissue Infections
o Other Bacterial Infections
• End User Insights (Revenue, USD Mn, 2021 - 2033)
o Hospitals
o Clinics
o Homecare Settings
o Others
• Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o GSK plc
o Sandoz Group AG
o Teva Pharmaceutical Industries Ltd.
o Sun Pharmaceutical Industries Ltd.
o Aurobindo Pharma Limited
o Lupin Limited
o CSPC Pharmaceutical Group Limited
o North China Pharmaceutical Group Corporation
o United Laboratories International Holdings Limited
o ACS Dobfar S.p.A.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Clavulanate Potassium Market, By Formulation Type
Global Clavulanate Potassium Market, By Application
Global Clavulanate Potassium Market, By End User
Global Clavulanate Potassium Market, By Distribution Channel
Global Clavulanate Potassium Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trends
4. Global Clavulanate Potassium Market, By Formulation Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Oral Formulations
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Injectable Formulations
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Clavulanate Potassium Market, By Application, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Respiratory Tract Infections
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Urinary Tract Infections
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Skin and Soft Tissue Infections
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Other Bacterial Infections
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Clavulanate Potassium Market, By End User, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Homecare Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Clavulanate Potassium Market, By Distribution Channel, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Clavulanate Potassium Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
9. Competitive Landscape
o GSK plc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Sandoz Group AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Sun Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Aurobindo Pharma Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Lupin Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o CSPC Pharmaceutical Group Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o North China Pharmaceutical Group Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o United Laboratories International Holdings Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o ACS Dobfar S.p.A.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
10. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
11. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on 'Clavulanate Potassium Market' - Global forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們